PEAK BIO, INC.
None
None, None [HQ]
PKBO/Financial Reporting
Income Statements
5 Sheets · Starting from 2019In Million USD. Margins, Growth Rates In %
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | - - | - - | |
|
EPS
|
- - | - - | -0.48 | -0.74 | - - | |
| Diluted in mil. | - - | - - | -0.48 | -0.74 | - - | |
|
Profit
|
- - | - - | - - | - - | - - | |
| Gross Margin | - - | - - | 100.00 | 99.98 | 99.97 | |
| Pre Tax | - - | - - | -8.00 | -13.00 | - - | |
| Profit Margin | - - | - - | -1,554.11 | -2,166.06 | -0.34 | |
| ETR | - - | - - | -1.00 | 0.56 | - - | |
| Net | - - | - - | -8.00 | -13.00 | - - | |
| Profit Margin | - - | - - | -1,569.65 | -2,153.88 | -0.34 | |
| EBITDA | - - | - - | -8.00 | -11.00 | - - | |
| EBITDA Margin | - - | - - | -1,682.49 | -1,954.70 | -0.37 | |
| Operating Income | - - | - - | -9.00 | -11.00 | - - | |
| Operating Margin | - - | - - | -1,715.95 | -1,949.68 | -0.38 | |
| Interest Income | - - | - - | - - | - - | - - | |
| Loss | - - | - - | -9.00 | -12.00 | - - | |
| Cost of Revenue | - - | - - | - - | - - | - - | |
|
Operating Expenses
|
- - | - - | -9.00 | -12.00 | - - | |
| R&D | - - | - - | -7.00 | -3.00 | -1.00 | |
| G&A | - - | - - | -2.00 | -8.00 | - - | |
| SG&A | - - | - - | -2.00 | -8.00 | - - | |
| S&M | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | |
| Interest Expenses | - - | - - | - - | - - | -2.00 | |
| Other Expenses | - - | - - | - - | -1.00 | - - | |
|
WA Shares Outstanding
|
3.00 | 6.00 | 17.00 | 17.00 | 29.00 | |
| Diluted | 3.00 | 6.00 | 17.00 | 17.00 | 29.00 |